No Data
Express News | Eloxx Pharmaceuticals Inc: Under Terms of Deal, Co Is Eligible for Additional Development, Regulatory, Sales Milestones of up to $470 Mln
Express News | Eloxx Pharmaceuticals Inc: Zkn-013 Has Been Exclusively Licensed to Almirall, S.A. Who Has Global Rights to Develop and Commercialize Zkn-013
Press Release: Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Express News | Eloxx Pharmaceuticals Inc: Signed Global Licensing Partnership for Zkn-013 With Almirall Pharmaceuticals With $3M Upfront and up to $470M in Milestones
Express News | Eloxx Pharmaceuticals Inc: Elx-02 Granted Orphan Drug Designation (Odd) From U.S. Food and Drug Administration (FDA) for Treatment of Alport Syndrome
Express News | Eloxx Pharmaceuticals Provides Elx-02 and Zkn-013 Program Updates
Moomoo Buddy : Dear client, in order to trade in the OTC market, you have to complete the OTC risk disclosure first. If you have not completed it yet, please click [Trade] on the detailed quotes page for an OTC stock and complete the OTC risk disclosure.
You can also click https://risk.us.moomoo.com/risk-disclosure/23 to complete the OTC risk disclosure.
Please note that not all OTC stocks are available to trade.
For more details about the OTC market, please check https://www.otcmarkets.com/stock
OTC Market Regular Trading Hours: You can also contact us on Monday through Friday 09:30 a.m. - 04:00 p.m. ET. Moomoo Financial Inc. customer service phone support is +1-888-721-0610(English), +1-888-721-0660(Chinese)
Thank you for your understanding.